Fitzsimmons W E, Postelnick M J, Tortorice P V
Department of Pharmacy, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612.
Drug Intell Clin Pharm. 1988 Jul-Aug;22(7-8):598-600. doi: 10.1177/106002808802200719.
Disparity exists in published recommendations for monitoring of vancomycin serum concentrations. To evaluate the degree of disparity of practice in Illinois, directors of pathology of 202 Illinois hospitals were surveyed to assess their vancomycin monitoring practices. Of the 202 surveys mailed, 82 were returned for a response rate of 41 percent. Most hospitals have 200-500 beds (60 percent) and are nonteaching institutions (72 percent). Two thirds of the hospitals sent vancomycin to an outside laboratory for analysis. Timing of postinfusion (peak) concentrations ranged from 0 minutes following end of infusion to 360 minutes. Approximately one half of the institutions reported a peak therapeutic range of 30-40 mg/L at 30 minutes following end of infusion. A great majority of institutions were consistent in recommended trough range, with 48 of 55 reporting 5-10 mg/L. Although there is some consistency among at least half of the hospitals, there is a great deal of variability among the other half in peak monitoring guidelines.
关于万古霉素血清浓度监测的已发表建议存在差异。为评估伊利诺伊州的实际差异程度,对202家伊利诺伊州医院的病理科主任进行了调查,以评估他们的万古霉素监测实践。在邮寄的202份调查问卷中,有82份被退回,回复率为41%。大多数医院有200 - 500张床位(60%),且为非教学机构(72%)。三分之二的医院将万古霉素送到外部实验室进行分析。输注后(峰值)浓度的测定时间从输注结束后0分钟到360分钟不等。约一半的机构报告称,输注结束后30分钟时的峰值治疗范围为30 - 40mg/L。绝大多数机构在推荐的谷浓度范围上是一致的,55家机构中有48家报告为5 - 10mg/L。虽然至少一半的医院之间存在一些一致性,但另一半医院在峰值监测指南方面存在很大差异。